Lumen Raises $13M for New Biotech Production Platform


Lumen Bioscience, a synthetic biotechnology company developing a novel bio-based product development platform, announced today it has raised $13 million of new capital, including a Series A investment round totaling $11.2M and a $1.8M grant from the US Department of Energy. The financing was led by Avista Development, BioEconomy Capital, company founders and other Seattle-area biotech investors.



from Biotech News